Chisholm G D, Carne S J, Fitzpatrick J M, George N J, Gingell J C, Keen J W, Kirby R S, Kirk D, O'Donoghue E P, Peeling W B
University Department of Surgery/Urology, Western General Hospital, Edinburgh, UK.
Postgrad Med J. 1995 Mar;71(833):136-42. doi: 10.1136/pgmj.71.833.136.
The prostate gland has attracted a remarkable increase in interest in the past few years. The two most common diseases of this gland, benign prostatic hyperplasia and carcinoma of the prostate, have been brought into greater prominence by new diagnostic methods, public interest, and a wider choice of surgical and non-surgical treatments. Uncertainty about the significance of these changes has occurred because of the rapidity of change, the profusion of statements, opinions and promotions, and the relatively little guidance available from the profession. Ten urologists and two general practitioners have reviewed the relevant evidence about these two prostate diseases and the newer diagnostic methods; their conclusions are summarised here. Management options and guidance on clinical practice are also discussed. Because of a number of unresolved diagnostic and management issues, detailed requirements for practice guidelines have not been specified.
在过去几年中，前列腺受到了人们极大的关注。该腺体的两种最常见疾病，良性前列腺增生和前列腺癌，由于新的诊断方法、公众的关注以及更多的手术和非手术治疗选择而变得更加突出。由于变化迅速、各种声明、观点和宣传大量涌现，以及该领域提供的指导相对较少，人们对这些变化的意义存在不确定性。十位泌尿科医生和两位全科医生回顾了有关这两种前列腺疾病及更新的诊断方法的相关证据；他们的结论在此进行总结。还讨论了管理选项和临床实践指南。由于存在一些未解决的诊断和管理问题，尚未明确实践指南的详细要求。
